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ABSTRACT Using a recently reported computational method, we describe an approach to model the structure of EmrE,
a proton coupled multi-drug transporter of Escherichia coli. EmrE is the smallest ion-coupled transporter known; it functions as
an oligomer and each monomer comprises four transmembrane segments. Because of its size, EmrE provides a unique
experimental paradigm. The computational method does not afford a unique solution for the monomer. The experimental
constraints available were used to select the most likely structure and to dock two monomers together to yield a dimer. The
model is further validated by modeling of Hsmr, an EmrE homolog with a remarkable amino acid composition with over 40% of
Ala and Val. The Hsmr model is similar to that of EmrE, with the majority of the Ala or Val residues facing the lipid. In addition,
the model of EmrE features a putative substrate-binding site very similar to that observed in BmrR, a transcription activator of
multi-drug transporters, with a similar substrate proﬁle. The two crucial residues that couple proton ﬂuxes with substrate binding
in the homo-dimer of EmrE, Glu-14, have a spatial arrangement that agrees with proposed molecular mechanisms of transport.
INTRODUCTION
Extensive crystallographic, biophysical, and theoretical
studies have provided an in-depth understanding of the
mechanism of ion channels and redox, light and ATP-driven
ion pumps (Capaldi and Aggeler, 2002; Chung and
Kuyucak, 2002; Booth et al., 2003). A different, yet highly
important group of membrane proteins is the family of
transporters. Multi-drug and drug-speciﬁc efﬂux systems are
responsible for clinically signiﬁcant resistance to chemo-
therapeutic agents in pathogenic bacteria, fungi, parasites,
and in human cancer cells (Nikaido, 1994; Paulsen et al.,
1996a,b; Van Bambeke et al., 2000). However, the scarcity
of structural information for ion-coupled transporters has
impeded our understanding of the mechanism of these
important proteins. Only recently, high-resolution structures
of ion-coupled transporters are becoming available (Chang
and Roth, 2001; Locher et al., 2002; Murakami et al., 2002;
Abramson et al., 2003). However, our structural knowledge
of these proteins is still very scarce and other approaches to
obtain structural information are needed.
Computational searches of the conformational space of
helix bundles have been used to model aspects of membrane
protein structure and function. Due to the complexity of the
problem, most approaches either focused on membrane
proteins featuring just two helices, or on homo-oligomeric
bundles, for which symmetry considerations can reduce the
conformational space to be searched (Adams et al., 1995,
1996; Grice et al., 1997; Forrest et al., 1999; Briggs et al.,
2001; Fleming and Engelman, 2001; Betanzos et al., 2002;
Kim et al., 2003). Recently, a new method has been in-
troduced (Gottschalk, 2004) that allows the modeling of
small, nonsymmetrical helical bundles. The method distin-
guishes itself from the earlier method in two ways: a), it does
not regard the total interaction energy as scoring function,
but instead focuses on individual helices in the bundle, and
b), reduces the computational effort by regarding the
backbone of the helices as rigid bodies, while allowing the
side chains to be ﬂexible. This approximation reduces the
computational effort signiﬁcantly and has been demonstrated
to give reliable results (Gottschalk, 2004).
Phylogenetic studies show that efﬂux systems are associ-
ated with ﬁve superfamilies of transporters (Chung and Saier,
2001). One of these includes a family of small multi-drug
resistance (SMR) conferring proteins. The SMR family con-
sists of small hydrophobic proteins of ;100 amino acid res-
idues with four transmembrane a-helical spanners (Paulsen
et al., 1996a,b). These proteins function as oligomers
(Yerushalmi et al., 1996; Rotem et al., 2001) and remove
cationic drugs from the cytoplasm using a drug/H1 antiport
mechanism (Paulsen et al., 1996a,b; Schuldiner et al.,
2001a,b). The most extensively characterized SMR protein
is EmrE, from Escherichia coli. The secondary structure of
EmrEwas determined by a variety ofmethods including high-
resolution NMR studies (Fig. 1 A) (Schwaiger et al., 1998).
The four transmembrane segments in EmrE are tightly packed
in the membrane without any continuous aqueous domain, as
was shown by FTIR and cysteine scanning experiments
(Arkin et al., 1996; Steiner Mordoch et al., 1999). These
results suggest the existence of a hydrophobic pathway
through which the substrates are translocated. Glu-14, the
only membrane-embedded charged residue is highly con-
served in the SMR family (Ninio et al., 2001). This residue
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FIGURE 1 Sequences and secondary structure of EmrE and Hsmr. (A) The sequences of EmrE and Hsmr are shown, with identical residues having a black
background and similar residues a gray background. The shown secondary structure has been determined for EmrE using high-resolution NMR experiments.
(B) Information content of a multiple alignment of 14 highly homologous sequences including EmrE and Hsmr is shown as sequence logos, generated with the
web-based application WebLogo (http://weblogo.berkeley.edu). The overall height of each logo indicates the conservation at this position, whereas the height
of each individual residue indicates the frequency of occurrence of this particular amino acid at this position. The topmost amino acid at each position
corresponds to the consensus sequence.
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has an unusually high pK and is an essential part of the
binding domain, shared by substrates and protons (Muth and
Schuldiner, 2000; Yerushalmi and Schuldiner, 2000a,b,c).
Cross-linking experiments with EmrE provided important
structural constraints. These studies suggest that helix 1 and
helix 4 of the homo-dimer are at the interface in a crossover
fashion (Soskine et al., 2002). Also a loop between helices 2
and 3 has been shown to cross-link. The location of helix
1 at the dimer interface has been further corroborated by
spin-labeling experiments (Koteiche et al., 2003). Addition-
ally, these experiments provided information about the
rotational orientation and tilt of helix 1.
Here, we describe a structural model of EmrE, which has
been obtained by generating a large library of random
conformations as described earlier (Gottschalk, 2004). For
validation of the model of EmrE, we additionally calculated
a model of an archaeal homolog of EmrE, Hsmr. Hsmr
displays a remarkable amino acid composition of over 40%
valine and alanine residues (Fig. 1 A) (Ninio and Schuldiner,
2003). The distribution of valine and alanine residues within
the trans-membrane domains of Hsmr is not random. Many
of these abundant residues appear to be clustered in
structural domains that are not essential for activity (Ninio
and Schuldiner, 2003). This resembles the result of an
alanine scan mutagenesis experiment, pointing out instanta-
neously the residues that are important for the function of the
protein, and therefore cannot be replaced with valine or
alanine. Mutational studies that identify important residues
are commonly used to validate structural models. Further-
more it has been shown that a parallel search of homologous
sequences can serve to discriminate between near-native and
nonnative structural models (Briggs et al., 2001). Since the
amino acid composition of Hsmr resembles the result of an
extensive alanine scan and the Hsmr sequence is homolo-
gous to the EmrE sequence, modeling of Hsmr provides
a combination of mutational validation and validation by
means of homology considerations. For further validation
using homology considerations, fourteen highly homolo-
gous sequences—including EmrE and Hsmr—have been
aligned and the conservation grade has been visualized with
Sequence Logos (Fig. 1 B).
The monomeric models for both homologous proteins,
EmrE and Hsmr, are very similar. The monomeric model of
EmrE has been dimerized using cross-linking constraints.
The dimeric model of EmrE provides novel insight for the
understanding of the function of these proteins at an atomic
level.
METHODS
All the calculations have been performed with the molecular modeling and
manipulation program CNS, version 1.1 (Brunger et al., 1998). The OPLS
force ﬁeld parameters were used (Jorgensen and Tirado-Rives, 1988).
Firstly the monomer of EmrE was modeled and secondly dimerized
based on cross-linking results. This two-step procedure emulates the two-
step model of membrane protein folding. Two topological models of the
monomer with different relative helix orientations (helix-order of model 1: 1
2 3 4, counting clockwise; helix-order of Model 2: 1 4 3 2 counting
clockwise) had to be tested. Other possibilities like helix order ‘‘1 3 4 2’’
could be excluded due to the shortness of the helix-connecting loops. The
starting structure was a bundle of four canonical a-helices. The helices
ranged from residues 4–26 (helix 1), 32–53 (helix 2), 58–76 (helix 3), and
85–105 (helix 4) as determined by NMR studies (Schwaiger et al., 1998)
(see also Fig. 1). The initial tilt of the helices was set to 27, which was
obtained as the average helix tilt angle by FTIR studies (Arkin et al., 1996).
Only left-handed crossing angles have been assigned during the search
procedure as suggested earlier (Torres and Arkin, 2000).
Generation of canonical helices
As input for the library generation served a bundle of four caconical
a-helices. The helices were built one by one as follows:
First the backbone was built so that the Ca-atoms rotated by 98.99 per
residue and had a rise of 1.5 A˚ per residue. The generated helix was initially
minimized with 3000 steps of Powell minimization with ﬁxed Ca-atoms.
Then 500 steps of a molecular dynamics simulation in Cartesian space with
NOE restraints of 2.8 A˚ between Ni and Oi14 and of 1.8 A˚ between Hi and
Oi14 with the temperature bath set to 300 K, and a time step of 0.5 fs
followed. This was followed by 3000 steps of Powell minimization with the
van der Waals repel term set to 1.5, followed by 3000 steps of Powell
minimization using the standard van der Waals term, followed by another
3000 steps of Cartesian dynamics at a temperature of 300 K with 3000 steps
and a time step of 0.5 fs. During all these steps up to now the Ca-atoms were
kept ﬁxed at their position. Then the helices were minimized with 1000 steps
of Powell minimization releasing the Ca-atoms, using NOE restraints of
2.8 A˚ between Ni and Oi14 and of 1.8 A˚ between Hi and Oi14 , followed
by 1000 steps of a Cartesian dynamics calculation coupled to a temperature
bath at 300 K with a step size of 0.5 fs, followed by another 1000 steps of
Powell minimization. The applied building scheme assures that the x1 angles
are in accordance with an a-helical secondary structure. This restricts the
rotamers of b-branched side chains like I or V to a single value, but does
not determine the rotamers of all the side chains unambiguously. The single
helices were then put together to form a bundle by separating the helix
centers to 10.4 A˚ at the appropriate angle (90 between three neighboring
helix centers for a 4-helix bundle). No further minimization was applied for
the start structure. Only the random conformations generated in the next step
were further minimized.
Library generation
In a helix bundle, each helix has four degrees of freedom: the rotation angle
around the long axis of the helix, the tilt relative to the membrane normal,
a vertical translation in the direction of the membrane normal, and a lateral
translation perpendicular to the membrane normal. A structure library of the
monomer consisting of 200,000 different conformations was generated by
assigning random values to each of the four structural parameters as
described elsewhere (Gottschalk, 2004). The assigned tilt angle had a range
of 27 6 20 (in accordance with FTIR studies), the rotation angle of 360,
the horizontal shift of 3 A˚ toward the helix center and 5 A˚ away from the
helix center, and the vertical shift 06 4 A˚. After assignment of the structural
parameters, a brief Powell minimization with 50 steps was performed
keeping the backbone restraint, and the interaction energies between each
single helix with the rest of the bundle helices were calculated.
Library evaluation
For the evaluation of the random structure library, only the nonbonded terms
(electrostatic and van der Waals terms) of the force ﬁeld energy were used.
The membrane was not included explicitly or by using solvation terms, but
membrane effects were implicitly included by setting the dielectric constant
Model of EmrE 3337
Biophysical Journal 86(6) 3335–3348
e of the surrounding medium to e ¼ 1. For each individual helix, the
nonbonded interaction energy between the designated helix and the rest of
the bundle has been calculated for all structures. The 1000 lowest energy
structures of each helix were further evaluated using a frequency analysis
of the structural parameters, assuming that native like values should be
predominant in the ensemble of low-energy conformations. A three-
dimensional histogram for each of the four structural parameters (tilt angle,
rotation angle, vertical shift, and horizontal shift) was generated, with the
structural parameter on the x axis, the energy on the y axis and the frequency
on the z axis. Peaks in each distribution of the structural parameter were
determined by visual inspection from these histograms. These peaks relate
to the predominant value of the respective structural parameter in the
low-energy ensemble. We assume that native like values are predominant at
low energies. From the obtained values the structures were combinatorially
generated by applying the respective geometric operation (like rotation by
20, if the peak in the distribution is at 20) to the respective helices. These
generated structures were compared to experimental data.
Inclusion of loop
To use the cross-linking data available, the loop between helix 2 and helix 3
had to be included. The loop consists of just four residues, I54PTG57. Out of
these residues, only G57, which is directly at the beginning of helix 3, has
been tested and shown to cross-link. The inclusion of the loop was
performed in two steps: ﬁrst the loop was interactively put into place
using SwissPdbViewer. This program generates a combinatorial list of
f-c-angles. The corresponding loop conformations are then evaluated with
an energy function based on the Gromos 96 force ﬁeld (van Gunsteren,
1996). The lowest energy conformation was chosen as initial loop
conformation. In a second step, the initial loop conformation was minimized
with 5000 steps of Powell minimization, using again the OPLS force ﬁeld
and keeping backbone of the rest of the protein ﬁxed during minimization.
No further simulation was performed in this step, since the loop was only
included for the next step, the formation of a dimer. During dimerization, the
loop was subjected to a slow cool molecular dynamics protocol.
The other loops are longer and we therefore refrain from trying to predict
their structure without inclusion of explicit solvents and/or the membrane
environment. As mentioned before, the complex environment of the lipid-
water interface certainly inﬂuences the loop conformation, so that for longer
loops standard procedures such as the one used by the SwissPdbViewer will
hardly produce reliable results.
Dimerization
For dimerization, a slow cool-simulated annealing/molecular dynamics
protocol was used, which is similar to reported protocols for docking dimers
using experimental restraints. To get an initial structure, the two monomers
were separated by 12 A˚ with the interfacial helices 1 and 4 facing each other,
forming a symmetrical dimer. The dimer was then subjected to a molecular
dynamics calculation in Cartesian space, ﬁrst heating the system to 1000 K
by assigning random velocities to each atom according to a Maxwell
distribution. The system was simulated in vacuo for 5000 steps with a step
size of 0.5 fs and then gradually cooled down to 0 K in 25 K steps with 100
time steps per temperature step with a step size of 1 fs. The calculated forces
were acting on all atoms, but certain NOE-like constraints restrained the
conformational space of the system. Three sets of constraints have been
used: the ﬁrst two sets are supposed to prevent the helices from unfolding
and the bundle from ﬂoating apart at the high temperatures of the initial step,
whereas the remaining set includes the cross-linking data. The ﬁrst set
restrained Ni and Oi14 to 2.8 A˚ to maintain the helical conformation, the
second set restrained the maximal distance between two neighboring helices
to 12 A˚, the third set comprised the cross-linking data (Table 1) and
restrained the Cb-atoms (which correspond to the Sb in cystein) of the
affected residues to 9.5 A˚ 6 0.5 A˚. 9.5 A˚ 6 0.5 A˚ is the distance the rigid
cross-linker used can span. 50 structures were generated with this molecular
dynamics protocol using CNS version 1.1, applying noncrystallographic
symmetry restraints with each monomer being a symmetry-related group.
The resulting structures were clustered using NMRclust (Kelley et al., 1996).
The highest populated cluster entails 23 structures with a spread of 1.3 A˚
within the cluster. Although standard docking algorithms normally use rigid
bodies, sometimes with certain side-chain ﬂexibility, the applied molecular
dynamics scheme allows conformational modiﬁcations during dimerization.
RESULTS
Model of the monomer of EmrE
The aim of this study is to provide a structural model of EmrE,
which is in agreement with all biochemical and biophysical
experiments. To this end, the EmrE monomer was modeled
using the computational approach described elsewhere
(Gottschalk, 2004). Although the computational search did
not lead to a unique solution, the biochemical data available
allowed us to discriminate the models. Only one topological
model has peaks at the rotation angle distribution for helices 1
and 4 that is compatible with the cross-linking results (Fig. 2).
In this model, helix 4 is oriented in accordance with the
cross-linking data, whereas helix 1 might have to rotate on
the order of 30 to be in accord with the cross-linking data.
The rotation angle distribution for the low energy structures
of helix 1 is rather broad, indicating a certain rotational
ﬂexibility of this helix in the monomer. A 30 rotation is
therefore in line with the observed rotation-angle distribu-
tion. As Glu-14 is the only charged residue in the membrane,
it appears reasonable that it is shielded from the membrane
and becomes exposed to a putative binding domain shared
with the neighboring monomer in the dimer.
Helix 3 has one predominant peak in the rotation-angle
distribution. This rotation angle places Tyr-60 in the center
of the bundle and Trp-63 at the interface between helix 3 and
helix 4. Both residues are evolutionary conserved (Ninio
and Schuldiner, 2003) and have been shown by mutational
work to be essential for functional or structural integrity
(Yerushalmi et al., 1995).
Helix 2 has one predominant peak in the rotation angle
distribution, but two smaller peaks are also detectable. The
TABLE 1 Cross-linking residues* used for dimerization
Monomer 1 Monomer 2
14 14
22 22
57 57
88 88
92 92
95 95
14 88
14 95
88 14
95 14
*Distance between the Cb-atoms of the cross-linking residues was set to
9.5 6 0.5 A˚.
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predominant angle places Tyr-40 and Phe-44 in the middle of
the bundle. Mutation of these residues signiﬁcantly decreases
expression levels of the protein, indicating an important
structural role (Steiner Mordoch et al., 1999). This structural
role would be explained by the obtained rotation angle, as the
residues are involved in key contacts in middle of the helix
bundle. Nevertheless, the data are not sufﬁcient to clearly
distinguish between different rotation angles of helix 2.
It has been observed earlier that lipid exposed residues
of GPCRs, the photosynthetic reaction center and of ion
channels are poorly conserved, whereas the protein core is
much higher conserved (Stowell and Rees, 1995; Baldwin
et al., 1997; Durell et al., 1999). To test whether a similar
pattern can be observed for this family of transporters,
fourteen highly homologous sequences, including EmrE and
Hsmr, have been aligned and the conservation grade has been
visualized using sequence logos (Fig. 1 B). Although helices
1, 2, and 4 show a clear helical pattern of conservation, helix
3 deviates from this pattern. In our model, the highly con-
served residues (marked with an asterisk in Fig. 1 B and in
Fig. 2) tend to cluster at the core of the bundle, whereas the
nonconserved residues are the lipid-facing residues.
The other structural parameters (tilt angle, lateral trans-
lation, and vertical shift) were also determined from the
energy-dependent distributions (Fig. 3). Most of the param-
eters are well-deﬁned by the distributions, whereas the
longitudinal shift of helix 3 has a rather broad plateau instead
of a peak. This structural parameter is not well-deﬁned by the
experimental data available and therefore error-prone.
As an additional test for the correctness of the obtained
model, we repeated the modeling procedure for the ex-
tremophilic EmrE-homolog Hsmr. To save computer time,
only one topological model was tested for Hsmr. We could
narrow down the search to this topological model, as the
purpose of the parallel modeling was to test whether or not
a structure similar to the model of EmrE can be found for
Hsmr. Since only one topology of EmrE is in accord with the
biochemical and structural data available, only this topology
had to be tested for Hsmr.
The generation and evaluation of the random structure
library for Hsmr using the same method as for EmrE yielded
36 possible models, much more than for EmrE. The high
content of Ala and Val leads to a diminished discrimination
between the rotation angles, since whole patches of the helix-
faces are looking virtually identical. One of these possible
models has an orientation very similar to EmrE. Helices 1, 3,
and 4 have approximately the same rotational orientation in
both models, but the rotational orientation of helix 2 differs
by ;90. Whereas for EmrE, the residues 40 and 44 face
directly into the interior of the four-helix bundle, they are
involved in contacts to helix 3 in the model of Hsmr. The
experimental data available do not allow us to distinguish
between these two possibilities of helix 2. In both cases the
residues appear to be involved in key contacts.
Closer analysis of the model of Hsmr reveals that the
majority of Ala and Val face the outside (Fig. 4). An extreme
example of the natural Ala scan is helix 1. Whereas one face
of the helix features a sequence homologous to EmrE, the
FIGURE 2 Rotational orientation of the EmrE monomer. (Left) The energy-dependent rotation angle distributions of the 1000 lowest energy conformations
are shown. From peaks in these distributions, the rotational orientation of the helices was determined (right). If more than one maximum in the rotation-angle
distribution exists, the chosen maximum is depicted by an arrow. Important residues are marked with an arrow. The cross-linking interfaces of helix 1 and helix
4 are oriented so that they can cross-link in a crossover fashion. The highly conserved residues are marked with an asterix and tend to accumulate at the core of
the protein.
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other face of the helix is nearly solely composed of Ala
(Ninio and Schuldiner, 2003). In our model all the helix
surfaces that predominantly feature Ala or Val face the lipid.
Mutational studies in EmrE demonstrate that replacement
of residues facing the side that is rich in Ala in Hsmr has
no functional consequences (Gutman et al., 2003), whereas
replacement of the residues which are on the conserved face
of helix 1 leads to changes in afﬁnity to TPP1 or impairment
in transport activity (Gutman et al., 2003). These data
strongly suggest that the Ala/Val side of the helix indeed
faces the lipid in the protein, as it does in our model. Also the
other helices display a strong tendency to accumulate either
FIGURE 3 Tilt, translation, and longitudinal shift of EmrE. For each of the helices, the 1000 lowest energy conformations were further evaluated by
a frequency analysis. For this analysis, a three-dimensional histogram with the frequency on the z axis, the energy on the y axis, and the respective structural
parameter on the x axis has been generated. The distribution for tilt angle, lateral translation, and longitudinal shift for each of the helices are shown here. The
maximum values were assumed to be near-native values. The conformation of the respective helix was then changed according to these values.
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Ala or Val on one face of the helix. The Ala or Val rich faces
coincide with the poorly conserved regions of the protein.
The highly conserved regions (marked with an asterisk in
Fig. 4) are—as in the case of EmrE—clustered at the protein
core. In each case the Ala/Val rich side of the helix faces the
lipid in our model, indicating that a), a model of Hsmr which
is energetically favored is very similar to our model of EmrE,
b), that in this model of Hsmr nearly all the Ala or Val face
the lipid, and c), that therefore the rotational orientation of
the helices in our model is in agreement with the basic
assumed explanation for the richness in Ala and Val, namely
that some evolutionary pressure forced the organism to
replace all nonessential (here, lipid-facing) residues of the
protein by either Ala or Val.
Dimerization of EmrE
For the dimerization of the monomeric structures the cross-
linking data obtained by Soskine et al., were used as NOE-
like constraints (Soskine et al., 2002). Cross-linking was
performed on single Cys mutants using the N,N-1,2-phenyl-
ene dimaleimide OPDM or mercury as cross-linker. Most of
the mutants used for cross-linking have been shown to be
active, indicating that the Cys-replacement had little or no
consequences on the structure (Soskine et al., 2002). Cross-
linking studies sample the whole conformational space
available for the protein. Thus no single structure does
necessarily fulﬁll all constraints obtained by cross-linking,
especially if one is dealing with highly dynamical systems
like the transporter EmrE. To ensure that all constraints relate
to a single structure, we excluded those from cross-linking of
residues, which are strongly affected by ligand binding
(Soskine and Schuldiner, unpublished results). It is more
likely that these constraints should correspond to a single
conformation, since conformational changes of the protein
upon ligand binding should affect certain cross-links, but not
those that correspond to the ligated structure.
As cross-linking has been observed between a Cys-
replacement at position 57 in the loop connecting helix 2
with helix 3, the loop has to be included for dimerization of
the two monomers. The loop consists of only four residues.
Despite the shortness of the loop it does ﬁt to the helix ori-
entation without causing any strain.
The distances of the residues cross-linking with OPDM
were set to 9.5 1 0.5 A˚ between the Cb-atoms of the
involved residues. OPDM is a rigid cross-linker, and the
distance is therefore well-deﬁned. This does not imply that
the dynamical movements of the protein are restricted to this
distance range. A total number of 10 intermonomer con-
straints was used (Table 1). It has been shown in computa-
tional docking studies that ﬁve constraints are sufﬁcient to
reliably dock two proteins. The number of constraints here
should therefore sufﬁce to obtain a well-deﬁned model
(Roisman et al., 2001).
Fifty dimeric structures were calculated starting from the
monomer (including the loop between helix 2 and helix 3)
with different initial velocities assigned to the atoms of the
start structure. These ﬁfty dimers were clustered according to
structural similarity. The highest populated cluster contains
23 structures with a spread of 1.3 A˚ in the cluster. This points
to awell-deﬁned structure with enough constraints to dock the
two monomers. The representative of this cluster was chosen
for further interpretation of the model (Fig. 5).
The rotational orientation of the helices remains virtually
unchanged after dimerization (Fig. 6 A).
The tilt angle of some of the helices changes signiﬁcantly.
The restraint between position 57 placed at the short loop
between helix 2 and helix 3 of both monomers leads to an
FIGURE 4 Rotational orientation of Hsmr. The rota-
tional orientation of Hsmr is shown as a helical wheel
projection. The Ala,Val-rich faces are exposed to the lipid,
whereas the highly conserved faces (depicted with an
asterisk) are at the core of the bundle. Whereas helix 1,
helix 3, and helix 4 are oriented as in EmrE, helix 2 is
rotated at around 100. The residue numbering of the
marked residues relates to EmrE.
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insertion of the N-terminal end of helix 3 between helix 1 and
helix 4 and a separation of the latter two helices (Fig. 6 B). In
our model of the dimer, helix 1 and helix 4 form a V-shaped
unit, which is open at the N-terminus of helix 1. This
V-shaped conformation of helix 1 and helix 4 in our model
implies that the N-terminus of helix 1 and the C-terminus of
helix 4 are inside the cell, exposing the negative charge of
Glu-14 to the ligand.
In spin-labeling experiments, it has been demonstrated
that Leu-7 and Ala-10 of helix 1 are solvent-exposed,
whereas Glu-14 and Thr-18 are restricted in their mobility
and close to the respective residues in the other monomer
(Koteiche et al., 2003). This is also true for our model
(Fig. 7 A). It has further been observed that residues 5, 8, 12,
16, 20, and 23 face the lipid, as they do in our model
(Fig. 7 B). Strikingly, ﬁve of these residues are Ala in the
Hsmr homolog and are not evolutionary conserved. In
addition, it was shown that residues 13, 19, and 21 have
a restricted mobility. This fact was interpreted as stemming
from contacts to neighboring helices. In our model, residues
13 and 21 face helix 2, whereas residue 19 faces helix 4
(Fig. 7 C). Hence, our model is in complete accordance with
the data from the spin labeling experiments, even though
these data have not been used in the modeling process, as
they were published only after the model was completed.
Thus they provide an independent and unbiased test of the
modeling success.
The four interfacial Helices 1 and 4, which line the
translocation pathway, were also subject to a conformational
search. The result of this conformational search demonstrates
that although the rotational orientation of the helices is
virtually identical in both cases, the tilt angle differs
signiﬁcantly (Fig. 8). Although the computational search
keeps the helices canonical throughout the process, the slow
cool molecular dynamics protocol used allows deviations
from ideal geometry. The conformation obtained by dimeriz-
ing the twomonomers features a central four helix bundle that
is composed of helices 1 and 4 and is open at the cytoplasmic
face. The separation of the helices causes Asn-102 to be
separated by more that 10 A˚, although Asn-102 has been
shown to cross-link to itself when no ligand is present. The
cross-linking data at this part of the bundle have been
excluded from the dimerization calculation, since adding
ligand strongly reduces the cross-linking ability of Asn-102
and the residues in its vicinity.
The conformation of the four central helices after the
conformational search on the other hand is a closed 4-helix
bundle, which is in accord with all cross-linking data
between helices 1 and 4. This difference in the tilt angle can
have different reasons. One reason might be that the applied
modeling scheme is not very accurate in describing the tilt
angle of the helices. A more intriguing interpretation is that
the closed bundle obtained by the conformational search of
the translocation pathway-lining helices 1 and 4 corresponds
to an unligated state, and that upon ligation the tilt of the
helices changes, exposing the charge of Glu-14 to the ligand.
If this is true, one might speculate about the function of Asn-
102. Not only is it highly conserved (Fig. 1 B), it also seems
to be involved in helix-helix contacts. In model helices, Asn
has been shown to be able to drive TM helix association
(Gratkowski et al., 2001; Lear et al., 2003), as does Glu (like
Glu-14 of helix 1). Thus there are two residues at the dimer
interface, Asn-102 and Glu-14, which are highly conserved
and which can drive helix-helix association. One can
speculate that Asn-102 is therefore important for correct
dimer formation and might even have a functional signiﬁ-
cance: upon ligand binding, helices 4 and 4* separate
according to our model. Asn-102 might drive reassociation
of helix 4 after ligand release.
Ligand binding
One pivotal residue in EmrE is Glu-14. It is the only charged
residue that is irreplaceable. Glu-14 binds ligand and
hydrogens mutually exclusively (Muth and Schuldiner,
2000; Yerushalmi and Schuldiner, 2000; Yerushalmi et al.,
2001). Even the conservative mutation E14D inhibits
transport, although not binding of substrate. In our model,
Tyr-60 is close to Glu-14. Also Tyr-60 has been shown to be
an essential residue (Lebendiker and Schuldiner, 1996).
Even a Y60F mutant is inactive. The biochemical data
together with the spatial closeness of the two residues in the
model imply an active involvement of both residues in ligand
binding. This implication can be corroborated by a compar-
ison of our model with the structure of BmrR (Zheleznova
et al., 1999). BmrR is a transcription activator for Bmr,
a Bacillus subtilis multi-drug transporter. BmrR and EmrE
share a very similar substrate proﬁle, and both bind TPP1.
FIGURE 5 Dimeric structure of EmrE. The model of EmrE as a dimer is
depicted together with the predicted binding site. One monomer is blue, the
other orange. The cross-linking side chains used for dimerization are shown.
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The crystal structure of the BmrR/TPP1 complex is known.
BmrR adopts a unique fold which resembles the b-barrel
motif and has no similarity to the all-helical EmrE-model. An
unusual feature of the unligated BmrR structure is the buried
Glu-134. Glu-134 turns out to be the central binding residue
for TPP1 and becomes exposed after a short helix, which
masks the binding site in the nonligated state, unfolds upon
ligation. The binding site of BmrR is dominated by the
negative charge of Glu-134, by the residues Tyr-51, Ala-53
of the b3-strand and Tyr-68, Ile-71 of the b4-strand. The
structure of BmrR in complex with TPP1 allows us to
compare the predicted binding site of EmrE with the
structurally determined binding site of BmrR. A comparison
shows that the spatial correlation of Glu-14 and Tyr-60 in our
model and E 134 and Y 51 of BmrR is very similar (Fig. 9).
Not only Glu-14 and Tyr-60, but also Ile-11 and Cys-95 of
our model structure have a counterpart in the x-ray structure
of the BmrR/TPP1 complex: Ile-71 of BmrR relates
structurally to Ile-11 in our EmrE model, Ala-53 of BmrR
relates to Cys-95 in our EmrE model (Fig. 8). Ile-11 is
relatively conserved within the family of SMR and mutation
to Cys reduces the afﬁnity to TPP1 10-fold. The observed
differences in side-chain conformation between the EmrE
model and the BmrR structure are within the error of the
model. Apparently half of the binding site of EmrE emulates
BmrR and is duplicated in the dimer.
The similarity between the two binding sites allows us to
manually dock TPP1 into the EmrE model. The predicted
binding mode is in agreement with observed cross-linking
behavior. Ligand binding inhibits cross-linking between Cys-
replacement at positions 102 and 99 in different monomers
(Soskine and Schuldiner, unpublished results). Although the
FIGURE 6 Effect of dimerization on EmrE. (A) The rotation of
each helix before dimerization (light gray) and after dimerization
(dark gray) is virtually unchanged, even for helix 1. To demonstrate
the rotation of each helix before and after dimerization, one arbitrary
residue per helix is shown. (B) Due to the restraint between the Gly-
57 in the loop connecting helix 2 with helix 3, helix 3 inserts between
helix 1 and helix 4, increasing the tilt angle of the latter and exposing
the negative charge of Glu-14 to the intracellular space.
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conformation of helices 4 and 4* obtained by the conforma-
tional search of the central helices allows cross-linking
between these helices, the distance in the ligand binding
conformation is too large. According to our model TPP binds
between these residues and the distance between helices in
two monomers may change upon binding. Adding ligand
inhibits labeling of Leu-7 and Ala-10 with water-soluble
substrates. In our model, ligand binds between these residues,
blocking the access of the labeling compounds (Schuldiner,
unpublished results).
Proton binding
Recently, the crystalline structure of the proton-coupled
transporter AcrB of the RND family has been reported
(Murakami et al., 2002). In the case of AcrB, as in the case
of EmrE, binding is mainly performed by hydrophobic or
p-stacking interactions in addition to charged interactions.
A structural comparison on top of this functional similarity
between the binding sites of the two proteins is not possible.
Although EmrE and AcrB do not share detectable se-
quence homology, have a structurally dissimilar binding site,
and are comprised of different numbers of helices (AcrB of
12 helices and EmrE of 8 helices in the functional dimer), it
would be interesting to see whether still certain similarities in
crucial parts of the proteins can be detected between the
crystal structure and our model. In AcrB, three charged
residues (Asp-407, Asp-408 and Lys-940) in the center of the
membrane have been implicated with proton binding. For
EmrE it has been shown that protons and substrate both bind
mutually exclusively Glu-14, which is also near the middle
of the membrane. Thus Glu-14 is not only the central residue
in substrate binding, but also the central proton-binding site.
It is interesting to note that the central helices of AcrB,
namely helix 4 and helix 10, and in our model of EmrE (both
times helix 1), which in both cases entail the proton-binding
FIGURE 7 Comparison with spin-labeling results. (A) Spin-labeling
experiments showed that Leu-7 and Ala-10 do not have restricted mobility
and are solvent exposed, as opposed to Glu-14 and Thr-18, which have
restricted mobility due to interaction with the corresponding residue in the
homodimer. This is in line with our model. (B) Surface of EmrE is shown.
The labeled residues have been shown to face the lipid by spin-labeling
experiments. (C) Contacts to other helices as predicted by our model are
corroborated by the spin-label results.
FIGURE 8 Central dimer-interface. (Left) Central dimer interface after
dimerization of the monomers. (Right) Central dimer interface as obtained
through conformational search of helices 1 and 4. The rotational orientation
between the two different conformations is identical, but the tilt is different.
Whereas the left conformation should correspond to a ligand binding
conformation, the right conformation might represent the unligated
conformation. This would indicate a change of the tilt upon complexation.
Whereas in the right conformation all cross-linking data between helices 1
and 4 are fulﬁlled, some cross-linking data have been excluded to obtain the
left conformation as described in the text.
FIGURE 9 Binding pocket of EmrE and BmrR. (Top) EmrE emulates half
of the binding pocket of BmrR. The main interaction partners in BmrR have
a counterpart in EmrE. In EmrE, this half of the binding pocket is duplicated
in the dimer.
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sites and are symmetry related, are oriented in a nearly
identical way (Fig. 10). Thus it seems as if not only the
ligand binding site of EmrE—as described in our model—is
very similar to a protein of known structure (BmrR), but also
the proton-binding site.
Comparison with 2D projection maps
Recently, 2D projection maps of EmrE with and without
ligand have been published (Tate et al., 2001,2003). The
projection maps show an asymmetric dimer of EmrE with the
proposed binding site nearly in the middle of the dimer. The
source of the asymmetry is unclear; the other structural data
available appear to be symmetric. Symmetry considerations
therefore guided our dimerization scheme. The discrepancy
between our symmetric model and the asymmetric projection
map is reﬂected by the different degrees of ﬁt between our
model and the projection maps. An excellent agreement of
one monomer of our model with the projection map is
obtained and allows a putative assignment of the projected
helices (Fig. 11). The symmetry-related second monomer of
the model does not match the projection images to the same
extent.
DISCUSSION
During the modeling procedure, the inﬂuence of the
membrane has been treated only implicitly by setting the
dielectric constant e of the surrounding medium to e ¼ 1.
Although this is an approximation, it has been applied before
with success. A global conformational search in vacuo of the
TM homo-dimeric protein glycophorin A resulted in a near-
native conformation (Adams et al., 1996). A global search
of the tilt- and rotation-angle of a number of oligomeric
proteins, considering just the force ﬁeld energy and treating
the membrane as amediumwith a dielectric constant of e¼ 1,
demonstrated that the native conformation is at an energy
minimum (Torres et al., 2001). The here applied modeling
and evaluation scheme has been shown to give reliable results
for two 4-helix bundles with known structure (Gottschalk,
2004). Furthermore, Duneau and co-workers compared
simulations of TM helices in vacuo with e¼ 1 and in explicit
lipid bilayer and concluded that the lipid bilayer has only little
inﬂuence on the conﬁgurational space available to a trans-
membrane peptide (Duneau et al., 1999). Therefore, for
a rapid scan of the conformational space available, it is
sufﬁcient to perform the calculations in vacuo. The success in
predicting helical transmembrane bundles without including
membrane components is a direct consequence of the two-
state character of membrane protein folding: the formation
and insertion of the helices is governed by helix-lipid
interactions, whereas the bundle formation is governed
by helix-helix interactions (Popot et al., 1987; Popot and
Engelman, 1990,2000). It has been demonstrated experimen-
tally that indeed helix-helix interaction terms can be separated
FIGURE 10 Superposition of central helices of EmrE and AcrB.
Although there is no signiﬁcant sequence similarity between the two
proteins, the proton-binding site as described by our model and found in the
x-ray structure of AcrB is remarkably similar. In both cases, the central,
symmetry-related helix constitutes the proton-binding site, although with
different residues: EmrE uses two Glu, whereas Acrb uses a Lys and two
Asp (only one shown).
FIGURE 11 Comparison with two two-dimensional projection map
reveals an excellent ﬁt of one monomer with the obtained densities (H1–
H4). The symmetry-related second monomer (H1*–H4*) ﬁts less well. This
might be caused by the asymmetry of the projection map.
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from helix-lipid interaction terms, underlining the correctness
of the assumption that the bundle formation is determined by
helix-helix interactions. Therefore, as opposed to soluble
proteins, for which solvation terms are crucial for a correct
description of the energy landscape, membrane proteins can
be described with sufﬁcient accuracy excluding terms that
describe helix-membrane interactions. This is probably not
true for helix-connecting loops, as these are at the membrane-
water interface, which is a complex environment with strong
inﬂuence of the charged lipid-headgroups and the water.
Therefore we did not attempt to model the structure of the
loops with the exception of the very short loop between helix
2 and helix 3. This loop had to be modeled to be able to use all
the cross-linking data.
The applied modeling scheme suffers from the fact that the
correct side-chain conﬁguration is not known. Preliminary
attempts to more rigorously reﬁne the side-chain conforma-
tion for each of the 200,000 members of the structure library
turned out to be too time-consuming to be practical.
Therefore, it cannot be ruled out that the initial side-chain
conformation inﬂuences the ﬁnal result. But it has been
demonstrated that b-branched or small residues are likely to
be at the helix-helix interface (MacKenzie et al., 1997;
MacKenzie and Engelman, 1998). This also appears to be
true for EmrE (Fig. 2, bottom), although not exclusively. For
b-branched or small residues, the side-chain conformation is
ﬁxed due to possible side-chain/backbone clashes (for the
b-branched residues like V or I) or due to the existence of
just a single rotamer (as for A and G). Also for Ser and Thr, it
is rather likely that hydrogen bonds with the backbone of the
same helix are formed, reducing the rotameric space to just
one rotamer. Large unbranched side chains like Met or to
a lesser extent Leu are nevertheless a possible source of error.
Yet, the applied minimization should reduce artiﬁcially high
energies if these side chains overlap. Furthermore, it has
been suggested that TM helices pack in a knob-into-hole
fashion (Dunker and Jones, 1978; Langosch and Heringa,
1998). This way of packing will be favored by the applied
scheme, since knobs-into-holes packing effectively reduces
the danger of overlapping side chains. Therefore, one might
think that the approximation used here, namely to allow the
side chains to adapt to the conformation during a brief
minimization, but not to perform a complete search of the
rotameric space, is a valid approximation. This is demon-
strated by the success of the applied method to predict the
conformations of 4-helix bundles with known structures
(Gottschalk, 2004).
In our opinion, different parts of the model have different
degrees of reliability. The position and rotational orientation
of helix 1 and helix 4 are supported by the following points:
a. Cross-linking studies, which provide very good structural
constraints.
b. The structural homology of the binding site of our model
with the binding site of the BmrR structure.
c. The similarity of the proton-binding site of our model
and of the proton-coupled transporter AcrB.
d. Identical orientations of these helices in the monomeric
model of Hsmr.
e. Recent spin-labeling experiments on helix 1.
Thus, we have high conﬁdence in the correct position of
these two helices. Helix 3 is not supported by cross-linking
constraints to the same extent as are helix 1 and helix 4.
However, cross-linking between Gly-57Cys in each mono-
mer, which is very close to helix 3, the involvement of helix
3 in ligand binding, which has been suggested based on mu-
tational data, and the spatial correlation of Tyr-60 to Glu-14,
which reﬂects a similar orientation in BmrR, all support the
assumption that helix 3 is also oriented correctly. This is
underlined by an identical orientation of the homologous
helix in the model of the monomer of Hsmr. The least data
are available for helix 2. In addition, the largest discrepancy
between the models of EmrE and Hsmr can be found for
helix 2. Thus we are least conﬁdent in the correct orientation
of this helix. However, based on the comparison between the
EmrE and Hsmr models and on the standard deviations of
the respective rotation-angle distributions, the error should
be within the order of 100 rotation angle. As a consequence
of the applied modeling scheme, the rotation angles are
probably modeled with a higher accuracy than the tilt angles
of the helices.
The modeling study describes EmrE as a transporter that
can couple two ﬂuxes, substrate and proton, with a minimal
number of essential residues due to ﬁne-tuning of electro-
static attraction and repulsion. The binding site in our model
is dominated by two stabilizing mechanisms, p-stacking and
electrostatic attraction. Both mechanisms of stabilization,
electrostatic attraction as well as p-stacking interactions, are
less dependent on changes in the geometry of the substrate
than tightly ﬁtting pockets dominated by van der Waals
interactions. Thus, EmrE can transport a large variety
of substrates, provided that they are positively charged and
aromatic. This is in accordance with the proﬁle of substrates
transported by EmrE.
Transport of solutes across the cell membrane is a very
basic phenomenon that enables life. Our modeling studies
enhance the understanding of the transport mechanism at an
atomic level. The results reported here integrate data from
many different sources and combine different experimental
procedures to obtain a single, consistent model. The cal-
culations provide a good starting point for further studies,
which can test the presented hypothesis about ligand binding
and the role of different amino acids in the transport cycle.
Note added in proof: After this article was accepted, the determination of
the three-dimensional structure of EmrE by electron cryomicroscopy of
two-dimensional crystals, including data to 7.0 A˚ resolution, was published
(Ubarretxena-Belandia, et al., 2003). This structure consists of a bundle of
eight transmembrane a-helices with one substrate molecule bound near the
center. At the current resolution, direct assignment of the amino acid
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sequence to each transmembrane helix was not possible; however our
model here is to a large extent in accordance with the EM reconstruction,
except for differences in the tilt angles. This might either reﬂect a weakness
in the modeling procedure or be due to the crystallization conditions or to
a different conformation of the protein bound to substrate. Furthermore, our
model is symmetric, whereas the Em structure shows an asymmetric
dimmer. An x-ray-structure of EmrE to 3.8 A˚ resolution was also published
(Ma and Chang, 2004). The two structures are not in accordance with each
other. Most of the features in the tetrameric model determined from x-ray
diffraction data do not correlate well with the experimental constraints
described here and elsewhere. It might therefore capture a conformation
radically different from the confomration sampled by the biochemical
studies and the Em crystallization experiments.
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